Home Tools

Approved / Repurposing

There are five libraries in this category: Approved Drug Library, Clinical Compound Library, Drug Repurposing Library, FDA-Approved Drug Library, and Preclinical Compound Library. The purpose of such screening collections is to enable rapid testing of compounds with demonstrated safety profiles in new indications, such as neglected or rare diseases, where there is less commercial motivation for expensive research and development.

Cat No.	product name
L1000	Approved Drug Library	A unique collection of 2342 approved drugs for high throughput screening (HTS) and high content screening (HCS);	2342 compounds
L3400	Clinical Compound Library	A unique collection of 1487 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);	1487 compounds
L4200	FDA-approved Drug Library	A unique collection of 1436 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);	1436 compounds
L3410	Preclinical Compound Library	A unique collection of 450 preclinical compounds for high throughput screening (HTS) and high content screening (HCS);	450 compounds
L9200	Drug Repurposing Library	A unique collection of 3216 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);	3216 compounds
L1010	FDA Approved & Pharmacopeial Drug Library	2950 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS);	2950 compounds

Approved Drug Library

L1000 compounds - 2342

Clinical Compound Library

L3400 compounds - 1487

FDA-approved Drug Library

L4200 compounds - 1436

Preclinical Compound Library

L3410 compounds - 450

Drug Repurposing Library

L9200 compounds - 3216

FDA Approved & Pharmacopeial Drug Library

L1010 compounds - 2950

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.